Baxter to produce A/H1N1 pandemic vaccine on large scale

Baxter International Inc. said on August 7 it completed production of its first commercial batches of C A/H1N1 pandemic vaccine in late July and is discussing plans for distribution with national health authorities to get appropriate authorizations.

The company said the vaccine was developed and commercially produced using this process within 12 weeks of receiving the A/H1N1 virus strain, wh...